Programs

Regulatory Updates

Total of 187 Records Returned

State: California

California All Facilities letter December 2023 COVID 19 vaccine.

Date Proposed : 11/14/2023

Date Effective : 11/14/2023

Program: Acute Care Hospital, Ambulatory Care, Ambulatory Surgical Centers (ASC), Critical Care Hospital, Home Care, Home Health, Home Infusion Therapy, Hospice, Palliative Care, Renal Dialysis, Sleep

​All Facilities Letter (AFL) Summary

  • Coronavirus Disease 2019 (COVID-19) Vaccine Recommendations for Clinically Eligible Individuals. (This AFL supersedes AFL 22-09.1)
  • The California Department of Public Health (CDPH) recommends facilities offer COVID-19 vaccinations to clinically eligible individuals.
  • This revision includes information related to updated (2023-2024 Formulation) COVID-19 vaccines.

Read More
State: North Carolina

North Carolina Home Care Agency and Home Assistance Services Provider Licensure Act 2023

Date Proposed : 03/13/2023

Date Effective : 11/9/2023

Program: Assisted Living, Home Care

Home Care Agency and Home Assistance Services Provider Provides that home assistance services providers shall, among other things, maintain liability insurance, inform all new clients that they do not provide health care or hands-on care, and conduct a criminal background check in each State where any contractor or employee was a resident during the past specified number of years; directs the Department of Health and Human Services to exempt certain home assistance services from home care licensure requirements.

Read More
State: Delaware

Delivery of Drugs

Date Proposed : 05/1/2023

Date Effective : 10/11/2023

Date Adopted : 09/13/2023

Program: Pharmacy

The Board implements subsection 5.1.5.1 prohibits the delivery of drugs to a patient's residence where such drugs are intended to be later transported to another location for administration and that require special storage, reconstitution or compounding. An exception is made for patients with bleeding disorders. The new subsection 5.1.5.2 prohibits delivery of a patient-specific compounded preparation to a practitioner's office or infusion center unless there is a written agreement between the dispensing pharmacist and the ordering physician or facility.

Read More
State: Washington

Continuing Pharmacy Education

Date Proposed : 02/2/2023

Date Effective : 09/23/2023

Date Adopted : 08/23/2023

Program: Pharmacy

This rule making requires pharmacists whose licenses expire on or after December 1, 2021, to complete the equivalent of 3.0 continuing pharmacy education (CPE) administered by an accreditation council for pharmacy education (ACPE) accredited provider prior to renewing their license. This also rewrites process conducted by the commission resulted in the creation of chapter 246-945 WAC and had the intent of updating regulatory standards around the practice of pharmacy, including license renewal standards.

Read More
State: Texas

Texas Health and Human Services updated HCSSA FAQs on October 6, 2023

Date Adopted : 10/6/2023

Program: Home Care, Home Health, Home Infusion Therapy, Hospice, Private Duty

HHSC Long-term Care Regulation has published updated Frequently Asked Questions (PDF) for Home and Community Support Services Agency providers.

Read More
State: All

DMEPOS – CMS has awarded the Appeals and Rebuttals Contract (ARC) to Chags Health Information Technology LLC

Date Posted : 10/9/2023

Date Effective : 10/9/2023

Program: Durable Medical Equipment, Prosthetics, Orthotics, and Supplies, Pharmacy

CMS has awarded the Appeals and Rebuttals contract (ARC) to Chags Health Information Technology LLC (C-HIT). C-HIT will begin accepting work on October 9, 2023. DME suppliers should send ALL appeals (corrective action plans and reconsideration requests) and rebuttals to C-HIT's contact information. Mailing address: P.O. Box 45266, Jacksonville, FL 32232 Email: [email protected] Phone 800-245-9206 Fax 866-410-7404 Friday October 6, 2023, was the last day the National Supplier Clearinghouse will accept them. They'll review and decide on appeals and rebuttals submitted before the transition date.

Read More